Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa
Dermatology · 2025
DOI: 10.1159/000543025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Dermatology, 2025. Verfasst von Haroon Saeed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nelson R. Mandela School of Medicine, University of KwaZulu Natal and Inkosi Albert Luthuli Central Hospital, Durban, Sout…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hidradenitis suppurativa (HS) is a chronic, debilitating condition that is underrecognized and poorly managed in South Africa. Hence, this study aimed to determine the prevalence of HS in KwaZulu-Natal, South Africa.
Methods
This multicenter, explorative, cross-sectional, and descriptive study was conducted on 500 persons accompanied by patients in a tertiary and private hospital in Ethekwini, KZN, South Africa, from 6th February to 16th March 2023. After obtaining consent, they were screened by a physician for HS on a validated questionnaire comprising questions for the presence of recurrent painful deep-seated boils in the axillae, breasts, groins, or perineum. Screened positive and selected (10%) negative persons were re-examined by a dermatologist. Relevant data on demographics, smoking, and body mass index (BMI) were also collected.
Results
From 500 participants, 9 were confirmed as HS and the point prevalence was 1.8%. The HS group comprised 8 females and 1 male, with a median interquartile range age of 36 years (IQR 29–42) and BMI of 27.3 kg/m2 (IQR 26.8–29.9). Four HS patients were of African ethnic origin (44.4%), and 5 were of Asian ethnic origin (55.6%). The majority of HS cases were graded as Hurley stage I (7/9 cases) and 2 were Hurley stage III. The sensitivity from the HS questionnaire was 100% and the specificity was 80%. The positive predictive value was 0.4 while the negative predictive value was 1.0.
Conclusion
The prevalence of HS in KwaZulu-Natal South Africa is 1.8%, with those of African and Indian ethnicity being more predisposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Nelson R. Mandela School of Medicine, University of KwaZulu Natal and Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
- Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
- Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
- Cochrane Denmark & Centre for Evidence-Based Medicine Odense (CEBMO), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Zitieren
APA
Saeed, H., Moodley, A., Medianfar, C. E., Christensen, R., Jemec, G. B. E., Bouazzi, D., & Mosam, A. (2025). Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa. Dermatology. https://doi.org/10.1159/000543025
Vancouver
Saeed H, Moodley A, Medianfar CE, Christensen R, Jemec GBE, Bouazzi D, et al. Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa. Dermatology. 2025. doi:10.1159/000543025
BibTeX
@article{Saeed2025,
author = {Saeed, Haroon and Moodley, Ameshin and Medianfar, Cecilia E and Christensen, Robin and Jemec, Gregor B E and Bouazzi, Dorra and Mosam, Anisa},
title = {Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa},
journal = {Dermatology},
year = {2025},
doi = {10.1159/000543025}
}
EUVIMED